Bone Health Technologies is developing a new standard of care for treating osteopenia, the precursor to osteoporosis.
Osteoboost has raised $8.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Osteoboost's investors include Emmeline Ventures, Portfolia, Good Growth Capital, Golden Seeds, Astia Angels.
Osteoboost is headquartered in San Francisco, United States.
Bone Health Technologies is developing a new standard of care for treating osteopenia, the precursor to osteoporosis.
Osteoboost is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Osteoboost — Funding & Investors." VCBacked, April 9, 2026, https://www.vcbacked.co/company/osteoboost. Accessed October 29, 2026.
VCBacked. (2026). Osteoboost — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/osteoboost
{{cite web |title=Osteoboost — Funding & Investors |url=https://www.vcbacked.co/company/osteoboost |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated